Since May 15, 2021, the amendment to the Narcotics Act has been in effect, which allows scientifically supported pilot projects for the controlled release of cannabis for recreational purposes.
These projects serve as a scientific basis for future legal provisions.
On September 25, 2020, Parliament passed a revision of the Narcotics Act, which introduces a legal basis for scientific pilot projects with cannabis that are limited in time and location with Article 8a.
This amendment, valid from May 15, 2021 for a period of ten years, defines the criteria and the application procedure for the pilot projects, regulated by the Ordinance on Pilot Trials under the Narcotics Act.
Controlled dispensing of medicinal cannabis
Reassessment of cannabis policy
Cannabis pilot projects in Switzerland mark a significant step in the research and re-evaluation of cannabis policy and use in the country.
These projects were set up to gather scientifically sound data on the impact of regulated cannabis use on society.
The goal is to lay the groundwork for potential future reforms in cannabis legislation while ensuring public health and safety.
Controlled consumption
Through these pilot projects, the Swiss government allows the legal sale and consumption of cannabis for non-medical purposes under strictly controlled conditions.
Participants in these studies can purchase cannabis products through registered pharmacies or special dispensaries.
The projects are designed to gain insight into the impact of a legal market on illicit trade, consumption habits, public health and prevention measures.
Selection and control
A central element of the pilot projects is the careful selection and control of cannabis products.
These must meet certain quality and safety standards to ensure safe use.
The projects also provide a unique opportunity for research into cannabis genetics and production as the demand for high-quality, regulated cannabis increases.
Researching evidence-based decisions
The participants in the pilot projects are scientifically monitored in order to document changes in consumption behavior as well as health and social effects.
This data is crucial for assessing the effectiveness of current drug policy and the potential benefits of a regulated cannabis market structure.
